Very Late Thrombosis After Bioresorbable Scaffolds: Cause for Concern?

Journal of the American College of Cardiology

Volumn 66, Issue 17, 2015, Pages 1915-1917

  Stone, Gregg W ^a   Granada, Juan F ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

bioresorbable scaffold; coronary artery disease; optical coherence tomography; thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT;

BARE METAL STENT; BIOMECHANICS; BIORESORBABLE SCAFFOLD; CORONARY STENT; DRUG ELUTING STENT; EDITORIAL; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MEDICAL TECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHUNT THROMBOSIS; STENT THROMBOSIS; THROMBUS ASPIRATION; TREATMENT FAILURE; TREATMENT RESPONSE; FEMALE; MALE; THROMBOSIS; TISSUE SCAFFOLD;

FEMALE; HUMANS; MALE; THROMBOSIS; TISSUE SCAFFOLDS;

EID: 84945930441     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.08.863     Document Type: Editorial

References (14)

1. M.C. Morice, P.W. Serruys, J.E. Sousa, and et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
2. A.J. Kirtane, A. Gupta, S. Iyengar, and et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
3. E.P. McFadden, E. Stabile, E. Regar, and et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
4. K. Yamaji, T. Kimura, T. Morimoto, and et al. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation Circ Cardiovasc Interv 3 2010 468 475
5. H. Gada, A.J. Kirtane, W. Newman, and et al. Five-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: Final results from the SPIRIT III trial J Am Coll Cardiol Intv 6 2013 1263 1266
6. L. Räber, S. Brugaletta, K. Yamaji, and et al. Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings J Am Coll Cardiol 66 2015 1901 1914
7. F. Otsuka, E. Pacheco, L.E. Perkins, and et al. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model Circ Cardiovasc Interv 7 2014 330 342
8. C.M. Campos, Y. Ishibashi, J. Eggermont, and et al. Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model Int J Cardiovasc Imaging 31 2015 471 482
9. Y. Onuma, P.W. Serruys, L.E. Perkins, and et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
10. Y. Onuma, P.W. Serruys, T. Muramatsu, and et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb everolimus-eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) J Am Coll Cardiol Intv 7 2014 1400 1411
11. G.S. Mintz Why are we so concerned with acute incomplete stent apposition? Eur Heart J Cardiovasc Imaging 16 2015 110 111
12. M.A. Mamas, and P.D. Williams Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database EuroIntervention 8 2012 196 204
13. M. Ohya, K. Kadota, T. Tada, and et al. Stent fracture after sirolimus-eluting stent implantation: 8-year clinical outcomes Circ Cardiovasc Interv 8 2015 e002664
14. F. Otsuka, R.A. Byrne, K. Yahagi, and et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment Eur Heart J 36 2015 2147 2159